SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-08-000021
Filing Date
2008-08-11
Accepted
2008-08-11 16:31:49
Documents
6
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 BIOSANTE 10Q FOR 2ND QUARTER 2008 biosanteq22008.htm 10-Q 714433
2 EXHIBIT 10.6 exhibit10w6.htm EX-10.6 82629
3 EXHIBIT 31.1 exhibit31w1.htm EX-31.1 10690
4 EXHIBIT 31.2 exhibit31w2.htm EX-31.2 11292
5 EXHIBIT 32.1 exhibit32w1.htm EX-32.1 4122
6 EXHIBIT 32.2 exhibit32w2.htm EX-32.2 4987
  Complete submission text file 0001023024-08-000021.txt   829683
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 081006744
SIC: 2836 Biological Products, (No Diagnostic Substances)